ABCAM Plc Director/PDMR Shareholding (4139F)
12 November 2015 - 3:26AM
UK Regulatory
TIDMABC
RNS Number : 4139F
ABCAM Plc
11 November 2015
For immediate release 11 November 2015
ABCAM PLC
("Abcam" or "the Company")
Director / PDMR Shareholding
Abcam plc (AIM: ABC), a global leader in the supply of life
science research tools, announces that it was notified today of the
following transactions completed today by a Director and PDMR of
the company.
Alan Hirzel, Chief Executive Officer, purchased 3,335 Ordinary
Shares of 0.2 pence each in the Company ("Ordinary Shares") at a
price of 580.0 pence per share. Following this transaction, Mr
Hirzel's total interest in the Company has increased by 3,335
Ordinary Shares to a total of 26,540 Ordinary Shares, representing
approximately 0.01% of the Company's issued share capital.
Suzanne Smith, Chief Legal Officer & Company Secretary
(PDMR), purchased 864 Ordinary Shares at a price of 578.1 pence per
share today. Following this transaction, Mrs Smith's total interest
in the Company has increased by 864 Ordinary Shares to a total of
4,269 Ordinary Shares, representing approximately 0.002% of the
Company's issued share capital.
For further information please contact:
+ 44 (0) 1223
Abcam 696 000
Suzanne Smith, Company Secretary
J.P.Morgan Cazenove - Nominated Adviser & Corporate + 44 (0) 20 7742
Broker 4000
James Mitford / Alex Bruce - Nominated Adviser
Notes to Editors
About Abcam
Abcam plc is a global leader in the supply of life science
research tools, with a wide range of products and expert technical
support, enabling scientists to analyse living cells at the
molecular level and improving the understanding of health and
disease.
Abcam is committed to providing scientists with an extensive
choice of reagents and tools, with the most comprehensive, honest
and up-to-date datasheets and customer reviews, fast delivery and
helpful customer service & technical support. The Company's
catalogue evolves with scientific research trends and is growing
each year to provide customers with products to meet their research
needs. The range now includes primary and secondary antibodies,
proteins, peptides, lysates, biochemicals, immunoassays and other
kits. Abcam also supports its customers by hosting a range of
global scientific events, forums and webinars, providing
opportunities for scientists to get together and present their
work.
Headquartered in Cambridge, UK, Abcam has nine global subsidiary
offices enabling local services and multi-language support and
sells to over 130 countries. The Company was founded in 1998, and
now employs over 820 people. Abcam was admitted to AIM in 2005
(AIM: ABC).
To find out more, please visit www.abcam.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSQFLFFEFFLFBZ
(END) Dow Jones Newswires
November 11, 2015 11:26 ET (16:26 GMT)
Abcam (LSE:ABC)
Historical Stock Chart
From Apr 2024 to May 2024
Abcam (LSE:ABC)
Historical Stock Chart
From May 2023 to May 2024